Drug recall · August 14, 2013
Methotrexate Injection recall
Why: Presence of Particulate Matter: Found during examination of retention samples.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Methotrexate Injection, USP, Preservative-Free, 1 g/40 mL (25 mg/mL), 40 mL Single Dose Vial, Rx only, Manufactured for: Sandoz Inc., Princeton, NJ 08540; Manufactured by: EBEWE Pharma Ges.m.b.H. Nfg.KG, A-4866 Unterach, AUSTRIA, NDC 66758-041-01.
- Lots / codes
Lot #: CL0996, Exp 12/13; and CJ4948, Exp 05/13
- Quantity
- 1,635 vials
- Company
- Sandoz Incorporated, Broomfield, CO
- Distribution
- Nationwide
- Initiated
- May 20, 2013 · Voluntary: Firm initiated
- Classified
- August 2, 2013
- Reported
- August 14, 2013
- Ended
- January 29, 2014
- How notified
- Press Release
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Methotrexate
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.